MarginsXMarginsX
Home › Markets › Health Care › TRUP

Trupanion Inc. (TRUP)

TRUP trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$36.16
+4.87% on the day
Market cap
$1.6B
Small cap
Revenue · 2025
$1.4B
+11.9% on 2024
Net income · 2025
$19.4M
1.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1371285/000137128526000018/0001371285-26-000018-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTRUP on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001371285
SEC industry codeHospital & Medical Service Plans
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.4B
Net income$19.4M
Operating income$13.8M
Net margin1.4%
Operating margin1.0%
Revenue growth+11.9%
Cash$138.0M
Total assets$915.0M
P/E (computed)80.5×
P/S (computed)1.1×

Warning signs

Cash runway
Cash-flow positive
$170.4M cash at September 30, 2026
Share count, 1 year
+0.2%
2025-10-30 to 2026-10-29 · +4.1% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$2.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$170.4M cash; operating cash flow $23.9M a quarter.Report 2026-09-30
Shares outstanding43,265,932 (2026-10-29); 43,198,164 a year earlier; 41,545,178 three years earlier.Cover page 2026-10-29
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-05
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Seattle, Washington, United StatesPCAOB Form AP 2026-02-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $2.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$405.6M$9.3M$30.7M$170.4M$104.5M$1.6B10-Q 2026-11-05
Q2 2026
2026-06-30
$392.9M$6.8M$21.0M$149.4M$106.9M$1.5B10-Q 2026-08-05
Q1 2026
2026-03-31
$384.0M$4.9M$14.6M$153.5M$109.3M$1.5B10-Q 2026-04-30
Q4 2025
2025-12-31
$376.9M$5.6M$29.3M$138.0M$101.8M$1.4B10-K 2026-02-13
Q3 2025
2025-09-30
$366.9M$5.9M$29.2M$154.8M$114.5M$1.4B10-Q 2026-11-05
Q2 2025
2025-06-30
$353.6M$9.4M$15.0M$122.7M$114.5M$1.4B10-Q 2026-08-05
Q1 2025
2025-03-31
$342.0M-$1.5M$16.0M$166.3M$128.9M$1.3B10-Q 2026-04-30
Q4 2024
2024-12-31
$337.3M$1.7M$23.7M$160.3M$127.5M$1.3B10-K 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-11-05
Latest annual report10-K2026-02-13
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.2%
1 month+29.8%
3 months+11.2%
Year to date-7.7%
1 year-12.5%
From 52-week high-10.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
LMRILumexa Imaging Holdings Inc.$14.79-0.14%$1.4B
FTREFortrea Holdings Inc.$19.79-2.03%$1.9B
VCYTVeracyte Inc.$24.01-1.32%$1.9B
FRNMFreenome Inc.$10.09-3.07%$1.1B
CSTLCastle Biosciences Inc.$32.75-3.08%$1.0B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier